Tissue plasminogen activator for blocked peritoneal dialysis catheters [2]

Pediatric Nephrology

Volumn 21, Issue 2, 2006, Pages 300-

  Krishnan, Raj G ^a   Moghal, N E ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Peritoneal dialysis; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; FIBRIN; HEPARIN; SODIUM CHLORIDE;

ABDOMINAL RADIOGRAPHY; BACTERIAL PERITONITIS; BLOOD CLOT LYSIS; CATHETER OCCLUSION; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETERIZATION; CONGENITAL NEPHROTIC SYNDROME; COST CONTROL; DIALYSATE; DRUG COST; HUMAN; LETTER; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RECURRENT DISEASE; SALVAGE THERAPY; TREATMENT PLANNING; URINE VOLUME; VASCULAR ACCESS; VASCULAR PATENCY;

CATHETERIZATION; CHILD, PRESCHOOL; EQUIPMENT FAILURE; FIBRINOLYTIC AGENTS; HUMANS; MALE; PERITONEAL DIALYSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 30944436544     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-005-2070-y     Document Type: Letter

References (6)

1. Wiernikowski JT, Crowther M, Clase CM, Ingram A, Chan A (2000) Stability and sterility of recombinant tissue plasminogen activator at -30 °C. Lancet 355:2221-2 10.1016/S0140-6736(00)02411-9
2. Bizjak ED, Mauro VF (1998) Thrombolytic therapy: A review of its use in acute myocardial infarction. Ann Pharmacother 11:172-4
3. Dutch JM, Yee J (2001) Successful use of recombinant tissue plasminogen activator in a patient with relapsing peritonitis. Am J Kidney Dis 37:149-53 11136181
4. Gittins N, Coulthard MG, Matthews JNS (2005) G66 Alteplase v heparin locks to maintain central line patency in haemodialysis lines. Arch Dis Child 90(Suppl 2):A30 10.1136/adc.2003.044578
5. Shea M, Hmiel SP, Beck AM (2001) Use of tissue plasminogen activator for thrombolysis in occluded peritoneal dialysis catheters in children. Adv Perit Dial 17:249-52 11510286
6. Sakarcan A, Stallworth JR (2002) Tissue plasminogen activator for occluded peritoneal dialysis catheter. Pediat Nephrol 17(3):155-6 10.1007/s00467-001-0780-3